SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-315935
Filing Date
2020-12-11
Accepted
2020-12-11 16:30:58
Documents
2
Group Members
ATHYRIUM CAPITAL HOLDINGS, LLCATHYRIUM CAPITAL MANAGEMENT, LPATHYRIUM FUNDS GP HOLDINGS LLCATHYRIUM OPPORTUNITIES 2020 LPATHYRIUM OPPORTUNITIES ADVISERS LLCATHYRIUM OPPORTUNITIES ASSOCIATES CO-INVEST LLCATHYRIUM OPPORTUNITIES ASSOCIATES GP LLCATHYRIUM OPP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d15911dsc13da.htm SC 13D/A 408539
2 EX-99.3 d15911dex993.htm EX-99.3 25987
  Complete submission text file 0001193125-20-315935.txt   437113
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
PROGENITY, INC. (Subject) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91551 | Film No.: 201383861
SIC: 8071 Services-Medical Laboratories

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 212-402-6925
Athyrium Capital Management, LP (Filed by) CIK: 0001728001 (see all company filings)

IRS No.: 263965190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A